Literature DB >> 463450

Measurement of circulating 1,25-dihydroxyvitamin D in man. Changes in serum concentrations during treatment with 1 alpha-hydroxycholecalciferol.

B Lund, B Lund, O H Sørensen.   

Abstract

A sensitive assay is described for measurement of circulating 1,25-dihydroxyvitamin D (1,25-(OH)2D) using rachitic chick intestinal cytosol binding protein. The metabolite was extracted from serum by diethyl ether and chromotographed on a Sephadex LH-20 column followed by high-pressure liquid chromatography. The concentration of 1,25-(OH)2D was then measured by a competitive protein-binding assay. The binding capacity of the protein was unchanged for 4 months. The inter- and intra-assay variations were both 11%. The standard curve was useful at serum concentrations ranging from 14 to 395 pmol/l (6 to 165 pg/ml). The normal mean concentration was 79.6 +/- 36.8 pmol/l (33.1 +/- 15.3 pg/ml). The serum 1,25-(OH)2D was studied in elderly subjects following administration of 1 alpha-hydroxycholecalciferol (1 alpha-OHD3) at different doses. Large variations occurred indicating individual rates of metabolism of 1,25-(OH)2D.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 463450     DOI: 10.1530/acta.0.0910338

Source DB:  PubMed          Journal:  Acta Endocrinol (Copenh)        ISSN: 0001-5598


  15 in total

1.  Vitamin D deficiency promotes skeletal muscle hypersensitivity and sensory hyperinnervation.

Authors:  Sarah E Tague; Gwenaëlle L Clarke; Michelle K Winter; Kenneth E McCarson; Douglas E Wright; Peter G Smith
Journal:  J Neurosci       Date:  2011-09-28       Impact factor: 6.167

2.  Effect of 1 alpha-hydroxycholecalciferol on psoriasis vulgaris: a pilot study.

Authors:  S Takamoto; T Onishi; S Morimoto; S Imanaka; S Yukawa; T Kozuka; Y Kitano; Y Seino; Y Kumahara
Journal:  Calcif Tissue Int       Date:  1986-12       Impact factor: 4.333

3.  Bone disorders following total gastrectomy.

Authors:  G Wetscher; E Redmond; C Watfah; G Perdikis; M Gadenstätter; R Pointner
Journal:  Dig Dis Sci       Date:  1994-12       Impact factor: 3.199

4.  Bone mineral loss, bone histomorphometry and vitamin D metabolism in patients with rheumatoid arthritis on long-term glucocorticoid treatment.

Authors:  B Lund; T L Storm; B Lund; F Melsen; L Mosekilde; R B Andersen; C Egmose; O H Sørensen
Journal:  Clin Rheumatol       Date:  1985-06       Impact factor: 2.980

5.  Abnormal vitamin D3 metabolism in patients with primary Sjögren's syndrome.

Authors:  K Müller; P Oxholm; O H Sørensen; M Thymann; M Høier-Madsen; K Bendtzen
Journal:  Ann Rheum Dis       Date:  1990-09       Impact factor: 19.103

6.  Effects of weight loss on serum 1,25-(OH)2-vitamin D concentrations in adults: a preliminary report.

Authors:  J Lemann; R W Gray; W J Maierhofer; N D Adams
Journal:  Calcif Tissue Int       Date:  1984-03       Impact factor: 4.333

7.  Plasma levels of parathyroid hormone, vitamin D, calcitonin, and calcium in association with endurance exercise.

Authors:  T Klausen; L Breum; H A Sørensen; S Schifter; B Sonne
Journal:  Calcif Tissue Int       Date:  1993-03       Impact factor: 4.333

8.  Osteopenia and osteomalacia after gastrectomy: interrelations between biochemical markers of bone remodelling, vitamin D metabolites, and bone histomorphometry.

Authors:  S Bisballe; E F Eriksen; F Melsen; L Mosekilde; O H Sørensen; I Hessov
Journal:  Gut       Date:  1991-11       Impact factor: 23.059

9.  Vitamin D status and measurements of markers of bone metabolism in patients with small intestinal resection.

Authors:  K V Haderslev; P B Jeppesen; H A Sorensen; P B Mortensen; M Staun
Journal:  Gut       Date:  2003-05       Impact factor: 23.059

10.  Long-term changes in bone mass after partial gastrectomy in a well-defined population and its relation to tobacco and alcohol consumption.

Authors:  M R Krogsgaard; A Frølich; B Lund; B Lund
Journal:  World J Surg       Date:  1995 Nov-Dec       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.